Your search for major depressive disorder returned 21 results

Researchers sought to evaluate the efficacy and safety of galcanezumab in patients with migraine in Japan.

In this review, authors focused on the psychiatric issues that often accompany migraine and the effects of botulinum toxin A on migraine.

In a systematic review, researchers examined the efficacy of digital headache management interventions for patients with a primary headache disorder.

Lauren R. Natbony, MD, takes us on a deep dive into the association between nutrition and dietary patterns in migraine, including proposed mechanisms, and the remaining needs in patient education and research.

An expert roundtable of headache specialists helps outline chronic migraine as its own entity, disparities and barriers to treatment, and a need for better research and education.

Dr Amit Akirov examines the evidence suggesting associations between migraine and major depressive disorder (MDD).

Paul G. Mathew, MD and Steven D. Bender, DDS, uniquely encounter patients with TMD and migraine in their respective practice and offer their insight regarding the diagnosis and management this often overlooked comorbidity.

A narrative review summarizes recent data on the pathophysiology, epidemiology, and burden of disease and treatment of menstrual migraine.

Researchers found evidence for a divergent association between lifetime MDD and the prevalence and severity of symptoms in patients with migraine.

The presence of psychiatric disorders in patients with idiopathic intracranial hypertension is associated with poor treatment outcomes.

Migraine with active headache may predict other painful physical symptoms in patients with major depressive disorder.

Cyclic vomiting syndrome (CVS) and benign paroxysmal torticollis (BPT) during infancy are associated with a high risk for developing headache later in life.

Aerobic exercise may be associated with a reduction in the number of migraine days.

People with migraines and comorbid mood disorders often need treatments that address both conditions, as well as management of sleep, stress, and lifestyle issues.

The findings suggest the importance of screening for posttraumatic stress disorder in this population.

In patients with migraine, structural and functional changes occur in brain regions that are not directly involved in processing pain signals.

Future research should focus on whether cogniphobia can be a modifiable factor in the treatment of patients with migraine.

Migraine was more significantly associated with pain or muscle soreness than anxiety disorders in patients with depression.

Acupuncture, neurostimulation, and other alternative treatments have been associated with up to a 50% reduction in headache days.

New findings suggest shared genetic etiology vs causal relationship in comorbid migraine and depression.

A multi-faceted approach is best when treating pediatric headache.